Clinical trials recruiting for Stomach Cancer

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
  NCT07354711 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
  NCT07578571 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
  NCT05426135 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Brodalumab in the Treatment of Immune-Related Adverse Events
  NCT06673329 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cancer Loyalty Card Study 2 (CLOCS-2)
  NCT06447064 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
  NCT06199895 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
  NCT06653478 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
  NCT06263088 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Large Language Models Assist in Tumor MDT
  NCT07504367 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 33 Years · Sex: All (male and female) · 6 locations
• Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
  NCT06821048 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
  NCT06532799 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 90 Years · Sex: All (male and female) · 1 location
• Target-specific immunoPET Imaging of Digestive System Carcinoma
  NCT06715839 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
  NCT04907643 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations
• cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
  NCT05366881 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 17 locations

Related conditions

Trials recruiting for Stomach Cancer often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Stomach Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.